Atlas Trials

Safety and Tolerability of BVS857 in Subjects With Insulin Resistance

Clinical trial NCT01435330 · COMPLETED

Trial details

NCT number
NCT01435330
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Insulin Resistance
Start date
2011-03-01
Primary completion
2012-03-01
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.